CD8A and melanoma: Further, the phenolic compound named gallic acid synthesized conjugated with NLG8189 has shown a clear immunomodulatory action in melanoma setup, regulating the CD4+/CD8+ ratio and the number of Treg cells, as well as significantly inhibiting melanoma growth both in vitro and in vivo [197].